Advertisement

Ads Placeholder
Loading...

CaliPharms, Inc.

KGET•PNK
Basic Materials
Agricultural Inputs
$0.00
$0.00(0.00%)
U.S. Market opens in 44h 11m

CaliPharms, Inc. (KGET) Stock Overview

Explore CaliPharms, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap11.9K
P/E Ratio-0.01
EPS (TTM)$-0.00
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$0.00

KGET Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CaliPharms, Inc. (KGET) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 11.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
-99.50%
All-Time (Max) Change
-100.00%

Contact Information

http://www.calipharmsinc.com
949-800-6645
33175 Temecula Parkway, Temecula, NaN, 92592

Company Facts

IPO DateDec 24, 2013
CountryUS
Actively Trading

Frequently Asked Questions